Myelodysplastic syndromes (MDS) and autoimmune conditions can overlap, and each may raise the risk of the other. Up to 30% of people with MDS also have an autoimmune disorder. Autoimmune conditions ...

Myelodysplastic syndromes (MDS) are blood cancers that reduce healthy blood cell production, leading to anemia, bleeding, fatigue, and frequent infections. Treatments target the affected blood counts, ...

Results show that it may be beneficial to add longitudinal monitoring of kidney function to the management of patients with MDS.

Myelodysplastic syndromes (MDS) are clonal disorders characterized by defective hematopoiesis leading to bone marrow failure, resultant peripheral blood cytopenias on a backdrop of genomic instability ...

Please provide your email address to receive an email when new articles are posted on . Individuals who smoked had more genetic mutations associated with myelodysplastic syndrome than nonsmokers.

Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting Myelodysplastic syndromes (MDS) ...

Researchers collected feedback from 20 clinicians implementing a telehealth serious illness conversation (SIC) with their patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

HOUSTON -- Survival in untreated, intermediate- and higher-risk myelodysplastic syndromes (MDS) failed to improve with the addition of the targeted agent venetoclax (Venclexta) to chemotherapy, a ...